Covadonga Alonso

Covadonga Alonso
Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria,
Consejo Superior de Investigaciones Científicas (INIA-CSIC), Madrid
Principal Investigator

Locking cells against Ebola virus.

• Carmen Gil (PL)
  Centro de Investigaciones Biológicas. Consejo Superior de Investigaciones Científicas (CIB-CSIC), Madrid

• Rafael Delgado
  Instituto de Investigación Biomédica Hospital 12 de Octubre (Imas12), Madrid

• Cesar Muñoz-Fontela
  Bernhard Nocht Institute for Tropical Medicine, Hamburg

Covadonga is a Professor of Research at INIA-CSIC. She leads the Virus-Host interaction lab at Biotechnology Department and was a visiting scientist at Tufts University. Alonso works to discover new targets for antivirals and vaccines against highly pathogenic viruses (SARS-CoV-2, Ebola, African swine fever virus) from a One Health perspective. She has been awarded several national and international grants, has authored more than 90 scientific articles and is the co-inventor of 11 patents. Prof. Alonso has been the Supervisor of 9 doctoral thesis, referee in National and International grant programs and Masters courses professor in Virology and Biotechnology. Chair of the Study Group Asfarviridae of International Committee Taxonomy of Virus (ICTV) is Vice-president of Sociedad Española de Virología (SEV). Dr. Alonso is co‐founder of the companies Alternative Gene ExpressionS.L. (ALGENEX) and LogicBiologyS.L. She graduated with honours (extraordinary award) at Medicine Degree Universidad Complutense and PhD Suma Cum Laude in Medicine from Universidad Autónoma Madrid. (Read full CV).

We work to discover targets for antivirals against highly pathogenic viruses from a One Health perspective. We study targets for SARS-CoV-2, Ebola, and African swine fever virus, based on host-pathogen interactions. We have identified cellular molecules that are crucial for viral infection, including entry, uncoating, and lipids regulation. Our goal is to increase knowledge on the mechanisms to develop an infection in order to find targets for new vaccination and antiviral strategies. The identification of key molecules that are crucial for a virus to complete its replication cycle raises the possibility to render cells resistant or sensitive to viral infection.

Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria,
Consejo Superior de Investigaciones Científicas
(INIA-CSIC)
Carretera de la Coruña, km 7,5
28040 Madrid, España
Tel.: (+34) 913 47 68 96

https://bit.ly/Biotec-INIA-CSIC
Email: [email protected]